Chatzidimitriou, Maria and Tsolakidou, Pandora and Kyriazidi, Maria Anna and Mitka, Stella (2024) Detection of KPC-3 producing Escherichia coli ST410 in Volos, Greece. Acta Microbiologica et Immunologica Hungarica, 71 (4). pp. 285-288. ISSN 1217-8950
|
Text
030-article-p285.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. Download (364kB) | Preview |
Abstract
Escherichia coli A382 was isolated in July 2024 from a positive blood culture obtained from the central venous catheter of a male patient undergoing chemotherapy at the Hospital of Volos, Thessaly, Greece. Whole-genome sequencing analysis revealed that the isolate A382 is E. coli belonging to the ST410 high-risk clone, which co-harbors the blaKPC-3 and blaSHV-182 genes on an IncX3 plasmid. It also harbors blaTEM-1 and has five replicons, as follows: IncX3, IncQ1, CoIRNAI, IncF1A, and IncFIB. Complete genome analysis revealed that E. coli A382 isolate carries a range of virulence factors (iutA, iucC, fimH, fdeC, yehA, yehD, yehC, yehB, cgs, ahha, ccI, hlyE, papC, irp2, fyuA, lpfA, and nlpl) and many other non-beta-lactam resistance determinants, including dfrA14 and sul2, but it is susceptible to aminoglycosides, nitrofurantoin, tigecycline, colistin and ceftazidime-avibactam. In conclusion in this study, we describe the phenotypic and genome characteristics of an extensively drug-resistant E. coli ST410.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Escherichia coli; KPC-3; bloodstream infection |
Subjects: | Q Science / természettudomány > QR Microbiology / mikrobiológia R Medicine / orvostudomány > R1 Medicine (General) / orvostudomány általában |
Depositing User: | Melinda Danyi |
Date Deposited: | 21 Jan 2025 12:19 |
Last Modified: | 21 Jan 2025 12:19 |
URI: | https://real.mtak.hu/id/eprint/213985 |
Actions (login required)
![]() |
Edit Item |